Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kingsley

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
American Journal of Hematology|July 18, 2018
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignanciesMichael R Savona, Kathryn Kolibaba, Paul Conkling, et al.
ESMO Open|April 1, 2026
Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.
Blood Advances|July 8, 2020
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AMLMolly C Kingsley, Hongbo M Xie, Bo-Rui Chen, et al.
Investigational New Drugs|August 23, 2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphomaTycel Phillips, Paul M Barr, Steven I Park, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
BMJ (Clinical Research Ed.)|May 13, 2021
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling studySantiago Romero-Brufau, Ayush Chopra, Alex J Ryu, et al.
Molecular Cell|August 6, 2021
ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependencyZhendong Cao, Krista A Budinich, Hua Huang, et al.
The Lancet. Haematology|November 18, 2022
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm studyMazyar Shadman, Ian W Flinn, Moshe Y Levy, et al.
Science (New York, N.Y.)|October 21, 2021
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in AfricaEduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, et al.
Science (New York, N.Y.)|September 15, 2022
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillanceHouriiyah Tegally, James E San, Matthew Cotten, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
American Journal of Hematology|July 18, 2018
Extended dosing with CC-486 (oral azacitidine) in patients with myeloid malignanciesMichael R Savona, Kathryn Kolibaba, Paul Conkling, et al.
ESMO Open|April 1, 2026
Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.
Blood Advances|July 8, 2020
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AMLMolly C Kingsley, Hongbo M Xie, Bo-Rui Chen, et al.
Investigational New Drugs|August 23, 2018
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphomaTycel Phillips, Paul M Barr, Steven I Park, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
BMJ (Clinical Research Ed.)|May 13, 2021
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling studySantiago Romero-Brufau, Ayush Chopra, Alex J Ryu, et al.
Molecular Cell|August 6, 2021
ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependencyZhendong Cao, Krista A Budinich, Hua Huang, et al.
The Lancet. Haematology|November 18, 2022
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm studyMazyar Shadman, Ian W Flinn, Moshe Y Levy, et al.
Science (New York, N.Y.)|October 21, 2021
A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in AfricaEduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, et al.
Science (New York, N.Y.)|September 15, 2022
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillanceHouriiyah Tegally, James E San, Matthew Cotten, et al.
Pageof 8